{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:32:57Z","timestamp":1784863977909,"version":"3.55.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1093\/chromsci\/bmx114","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T15:35:33Z","timestamp":1515425733000},"page":"317-326","source":"Crossref","is-referenced-by-count":11,"title":["Stability-Indicating HPLC and HPTLC Methods for Determination of Agomelatine and its Degradation Products"],"prefix":"10.1093","volume":"56","author":[{"given":"Maha M","family":"Abdelrahman","sequence":"first","affiliation":[{"name":"Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Alshaheed Shehata Ahmad Hegazy St., 62514 Beni-Suef, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim A","family":"Naguib","sequence":"additional","affiliation":[{"name":"Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Alshaheed Shehata Ahmad Hegazy St., 62514 Beni-Suef, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed R","family":"El Ghobashy","sequence":"additional","affiliation":[{"name":"Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., 11562 Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesma A","family":"Ali","sequence":"additional","affiliation":[{"name":"Medicolegal Authority, Justice Ministry, 114 Bairam El Tounsy St., El Sayeda Zeinab, 11647 Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,12]]},"reference":[{"key":"key\n\t\t\t\t20180317025251_bmx114C1","volume-title":"The Merck Index","year":"2006","edition":"14th Ed"},{"key":"key\n\t\t\t\t20180317025251_bmx114C2","volume-title":"Martindale: the complete drug reference","author":"Sweetman","year":"2009","edition":"36th ed"},{"key":"key\n\t\t\t\t20180317025251_bmx114C3","author":"European Medicines Agency","year":"2008"},{"key":"key\n\t\t\t\t20180317025251_bmx114C4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004850-200209000-00004","article-title":"Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study","volume":"17","author":"Loo","year":"2002","journal-title":"International Clinical Psychopharmacology"},{"key":"key\n\t\t\t\t20180317025251_bmx114C5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1192\/bjp.bp.112.120196","article-title":"Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials","volume":"203","author":"Koesters","year":"2013","journal-title":"British Journal of Psychiatry"},{"key":"key\n\t\t\t\t20180317025251_bmx114C6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/JCP.0b013e318172b48c","article-title":"A double-blind comparison of sexual functioning, antidepressant efficacy and tolerability between agomelatine and venlafaxine XR","volume":"28","author":"Kennedy","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"key\n\t\t\t\t20180317025251_bmx114C7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2165\/11534420-000000000-00000","article-title":"Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness","volume":"24","author":"Kennedy","year":"2010","journal-title":"CNS Drugs"},{"key":"key\n\t\t\t\t20180317025251_bmx114C8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0269881108096507","article-title":"Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale","volume":"24","author":"Montejo","year":"2010","journal-title":"Journal of Psychopharmacology"},{"key":"key\n\t\t\t\t20180317025251_bmx114C9","first-page":"037","article-title":"Determination of agomelatine by RP-HPLC","volume":"2","author":"He","year":"2010","journal-title":"West China Journal of Pharmaceutical Sciences"},{"key":"key\n\t\t\t\t20180317025251_bmx114C10","first-page":"652","article-title":"Determination of agomelatine in tablets by HPLC","volume":"29","author":"Yujing","year":"2012","journal-title":"Chinese Journal of Modern Applied Pharmacy"},{"key":"key\n\t\t\t\t20180317025251_bmx114C11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jpba.2013.04.016","article-title":"Quantification and structural elucidation of potential impurities in agomelatine active pharmaceutical ingredient","volume":"81","author":"Liua","year":"2013","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"key\n\t\t\t\t20180317025251_bmx114C12","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/bio.2642","article-title":"Evaluation of agomelatine stability under different stress conditions using an HPLC method with fluorescence detection: application to the analysis of tablets and human plasma","volume":"29","author":"El\u2010Shaheny","year":"2014","journal-title":"Luminescence: The Journal of Biological and Chemical Luminescence"},{"key":"key\n\t\t\t\t20180317025251_bmx114C13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpba.2014.02.005","article-title":"Multi-matrix assay of the first melatonergic antidepressant agomelatine by combined liquid chromatography-fluorimetric detection and microextraction by packed sorbent","volume":"95","author":"Saracino","year":"2014","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"key\n\t\t\t\t20180317025251_bmx114C14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jms.2020","article-title":"Validated LC-MS\/MS method for quantification of agomelatine in human plasma and its application in a pharmacokinetic study","volume":"47","author":"Patil","year":"2012","journal-title":"Journal of Mass Spectrometry"},{"key":"key\n\t\t\t\t20180317025251_bmx114C15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bmc.3008","article-title":"LC-MS\/MS method for the determination of agomelatine in human plasma and its application to a pharmacokinetic study","volume":"28","author":"Wang","year":"2014","journal-title":"Biomedical Chromatography"},{"key":"key\n\t\t\t\t20180317025251_bmx114C16","first-page":"5591","article-title":"Stability-indicating HPTLC method for quantitative stimation of Agomelatine in bulk and pharmaceutical dosage form","volume":"2","author":"Joshi Hitendra","year":"2013","journal-title":"World Journal of Pharmacy and Pharmaceutical Science"},{"key":"key\n\t\t\t\t20180317025251_bmx114C17","first-page":"531","article-title":"Stability-indicating chromatographic methods for determination of agomelatine in drug substance and drug product","volume":"8","author":"Rizk","year":"2017","journal-title":"Pharmceutica Analytica Acta"},{"key":"key\n\t\t\t\t20180317025251_bmx114C18","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5740\/jaoacint.15-0286","article-title":"Least-squares regression and spectral residual augmented classical least-squares chemometric models for stability-indicating analysis of agomelatine and its degradation products: a comparative study","volume":"99","author":"Naguib","year":"2016","journal-title":"Journal of AOAC International"},{"key":"key\n\t\t\t\t20180317025251_bmx114C19","author":"ICH","year":"2003"},{"key":"key\n\t\t\t\t20180317025251_bmx114C20","volume-title":"HPTLC: high performance thin-layer chromatography; quantitative analysis of pharmaceutical formulations","author":"Sethi","year":"1996"},{"key":"key\n\t\t\t\t20180317025251_bmx114C21","author":"ICH, Q2 (R1)","year":"2005"},{"key":"key\n\t\t\t\t20180317025251_bmx114C22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/3527604685","volume-title":"Method validation in pharmaceutical analysis","author":"Ermer","year":"2005"},{"key":"key\n\t\t\t\t20180317025251_bmx114C23","volume-title":"National formulary (NF19)","author":"The United States Pharmacopoeia (USP24)","year":"2000"}],"container-title":["Journal of Chromatographic Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/chromsci\/article-pdf\/56\/4\/317\/24394977\/bmx114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,17]],"date-time":"2018-03-17T02:53:13Z","timestamp":1521255193000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/chromsci\/article\/56\/4\/317\/4802230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,12]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,1,12]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/chromsci\/bmx114","relation":{},"ISSN":["0021-9665","1945-239X"],"issn-type":[{"value":"0021-9665","type":"print"},{"value":"1945-239X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,1,12]]}}}